$13.770
+0.465 (+3.38%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RNA-Prognose durch Analyse ähnlicher Charts
Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.94 (+1.21%). The 1-week path is $14.01 (+1.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Atrium Therapeutics Inc-Aktien kaufen?
Avidity Biosciences Inc appears to be a good buy right now due to its current price of $13.64, which is significantly below the analyst price target of $25, suggesting a potential upside of 83.5%. Additionally, the stock has shown a positive 20-day change of +20.18%, indicating a recent upward trend. However, investors should be cautious of the high insider selling activity, which has increased by 200.63% over the last month, indicating potential concerns among insiders.
RNA schloss am Tuesday bei $13.77, nachdem der Kurs +3.38% gestiegen ist
Atrium Therapeutics Inc (RNA) last closed at $13.77, gaining +3.38%. These facts feed the 1-day and 1-week RNA price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Atrium Therapeutics Inc (RNA) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RNA am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RNA
Historically the probability of a positive September return for RNA is 95.35%. October offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.